← SynDRA
SB-505124
SynDRA canonical compound SYN1965106 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
| Primary target(s) | ACVR1B | ACVR1C | TGFBR1 |
| Mechanism of action | ALK tyrosine kinase receptor inhibitor |
All known targets
Mechanisms of action (all sources)
- ALK tyrosine kinase receptor inhibitor
Cross-references
Synonyms
- SB 505124
- SB505124
- 2-(4-(benzo[d][1,3]dioxol-5-yl)-2-tert-butyl-1H-imidazol-5-yl)-6-methylpyridine
- CHEMBL226838
- 2-[4-(1,3-Benzodioxol-5-yl)-2-(tert-butyl)-1H-imidazol-5-yl]-6-methylpyridine
- 2-[5-(1,3-Benzodioxol-5-yl)-2-(1,1-dimethylethyl)-1H-imidazol-4-yl]-6-methylpyridine
- 2-[4-(2H-1,3-benzodioxol-5-yl)-2-tert-butyl-1H-imidazol-5-yl]-6-methylpyridine
- MLS006010969
- SCHEMBL373422
- GTPL6049
- CTK8E3615
- KS-00000XPS
- EX-A217
- DTXSID50431926
- AOB1766
- AOB5688
- MolPort-021-804-897
- CHEBI:100922
Look up SB-505124 in the interactive SynDRA portal →